Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet medical needs. The underlying technology was developed at McGill University and the Lady Davis Institute for Medical Research in Montreal.
MIM-D3, Mimetogen’s lead compound is currently being evaluated in a multi-center Phase 3 clinical stu...
Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet medical needs. The underlying technology was developed at McGill University and the Lady Davis Institute for Medical Research in Montreal.
MIM-D3, Mimetogen’s lead compound is currently being evaluated in a multi-center Phase 3 clinical study in the United States for the treatment of dry eye syndrome.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.